Porcine Health Management

Chosen Topics:

Immunology and Vaccinology

Dear applicant.
The invoice that you will get to become a member of the EAPHM, is automatically generated and is based on the information that is supplied by you.
When you require an invoice with your address, your company address and or a VAT number, these data must be entered by yourself. Under the 2018 EU privacy rules, these private data may not be asked for by the EAPHM. When you or somebody else pays the invoice, make sure that your name is mentioned on the payment form.

1 - 15 of 101

Contamination level of syringes used to administer porcine vaccines in Belgium and the Netherlands

Vaccines are produced in a sterile way. Under farm conditions however, they are not administered with sterile disposable syringes. It is likely that the contamination level of syringes influences the efficacy of the administered product and causes...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
HIPRA Benelux

PRRS post-vaccinal immune response to MLV in PRRS multivaccinated sows

PRRS MLV vaccines are used to prevent reproductive disorders due to PRRSV in sows. Vaccine efficacy was proven only in sows vaccinated once or twice. In vaccinated herds, sows receive multiple vaccine boosters. To date, no data are available on the...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
Anses, Laboratoire de Ploufragan, France

Effect of early PRRSV (Porcine Reproductive and Respiratory Syndrome virus) vaccination on pig health and performance: the earlier the better?

Vaccination is a cornerstone of infectious disease control, especially in intensive swine farming systems with high infectious pressure. Despite being very vulnerable, newborn piglets are not commonly vaccinated because most vaccines are susceptible to...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
Department of Animal Medicine, Production and Health (MAPS), University of Padua, Viale dell'Università 16, 35020 Legnaro (PD), Italy

Humoral and cellular immune responses after administration of innovative Mycoplasma hyopneumoniae bacterins in pigs

Current vaccines against Mycoplasma hyopneumoniae only provide partial protection against clinical symptoms and lung lesions. New vaccine formulations that include novel strains of the micro-organism formulated with innovative adjuvants could improve...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
Faculty of Veterinary Medicine, Ghent University, Belgium

Colostrum immune transfer evaluation in pigs by using Flu HI test at 3 weeks of age

Immune transfer via the colostrum in the pig can be investigated using a total IgG test in early life. However, the effectiveness of the different types of IgG for the immune response remains unknown. This is the reasoning behind looking at antibodies...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
IDT Biologika, 17 Rue du Sabot, 22 440 Ploufragan, France

Assessment of the replication of Porcine Reproductive and Respiratory Syndrome modified live virus attenuated vaccines in porcine alveolar macrophages

The method of attenuation influences the properties of modified live virus (MLV) vaccines. PRRSV is typically attenuated on simian cells, but a new vaccine, Suvaxyn PRRS MLV (vaccine S), was attenuated on a hamster-origin engineered cell line expressing...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
Zoetis

Results from 14 farrow-to-finish French farms before and after implementation of Coliprotec F4/F18

Post-weaning diarrhea (PWD) remains a major cause of economic losses for the pig industry. Coliprotec F4/F18 is a live non-pathogenic E. coli vaccine for active immunization of pigs against F4-EnteroToxigenic E. coli (ETEC) and F18-ETEC. This study...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
Elanco

Implementation of Coliprotec F4/F18 and a new feed program in a French farrow-to-finish farm to control post-weaning diarrhea and improve performances

Coliprotec F4/F18 is a live non-pathogenic E. coli vaccine for active immunization of pigs against F4-EnteroToxigenic E. coli (ETEC) and F18-ETEC. This study describes the implementation of Coliprotec F4/F18 and a feed program having an increased protein...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
Elanco

In-use stability of Coliprotec F4/F18, a live E. coli vaccine for oral suspension, in water acidifier at different pH values

Organic and inorganic acids are used to lower the pH of drinking water to increase the digestive enzymes activity, regulate the gut microbiota and reduce water contaminants. These products can interfere with the efficacy of oral live E. coli vaccines...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
Prevtec Microbia Inc, 3395 Casavant blvd. West, Saint-Hyacinthe, Québec, Canada

PRRS CONTROL: A FIELD CASE REPORT OF INTRADERMAL VACCINATION WITH TWO M.HYO AND PRRS VACCINES COMBINED

The pig respiratory disease complex is an important health concern for swine producers. Many pathogens are involved but M.hyopneumoniae (Mhyo) and PRRSv play a major role. For practical reasons Farmers requested a mix of two vaccines. This case report...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
SCOP de Vétérinaires BREIZHPIG

Dietary algal β-(1,3)-glucan, modulating inflammation and cell-mediated immune responses in piglets through their mother sow

Weaning is associated with stress, digestive disorders and growth performance depression, consequently antibiotics and minerals (ZnO) are used. Due to an increasing regulatory and consumer demand to reduce usage of those substances, because of concerns on...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
kemin europa nv

Safety of sows’ mass vaccination with attenuated PRRS vaccine in farms under PRRS stable status

Sows’ mass vaccination (SMV) with modified live virus vaccines (MLVv) is a very common strategy in order to control and prevent porcine reproductive and respiratory syndrome (PRRS) in breeding herds. Despite the safety of MLVv which have been widely...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
Laboratorios HIPRA S.A, Amer, Spain

Effect of mass-vaccinating sows with attenuated PRRSV vaccine on the PRRS status of breeding herds

Vaccinating sows with modified live PRRS virus vaccines (MLV) may result in transient shedding of the vaccine’s virus, which has the potential to be transmitted to their offspring. Therefore, sow mass vaccination (SMV) programs may affect PRRS status of...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
Laboratorios HIPRA S.A, Amer, Spain

In-use stability of Coliprotec F4/F18, a live E. coli vaccine for oral suspension, when used with a dextrose/electrolyte solution

Oral live E. coli vaccines against PWD can be administered to pigs from 18 days of age. These vaccines are made up into suspension with water to be orally administered and should be consumed within 4 hours. Administration of the vaccine with bowls is...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
Prevtec Microbia Inc, 3395 Casavant blvd. West, Saint-Hyacinthe, Québec, Canada

A comparative trial evaluating immune response, IL-10 and protective efficacy against a single HP-PRRSV challenge or in conjunction with PRRSV type 1...

The study was conducted to evaluate the protective efficacy of type 1 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (MLV) when administered intramuscularly (IM) or intradermally (ID) in pigs against either a single...
Type
Abstract
Year
2019
Topic
Immunology and Vaccinology
Affiliation
HIPRA